BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 15781647)

  • 1. The propeptide mediates formation of stromal stores of PROMIC-1: role in determining prostate cancer outcome.
    Bauskin AR; Brown DA; Junankar S; Rasiah KK; Eggleton S; Hunter M; Liu T; Smith D; Kuffner T; Pankhurst GJ; Johnen H; Russell PJ; Barret W; Stricker PD; Grygiel JJ; Kench JG; Henshall SM; Sutherland RL; Breit SN
    Cancer Res; 2005 Mar; 65(6):2330-6. PubMed ID: 15781647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promotion of angiogenesis by ps20 in the differential reactive stroma prostate cancer xenograft model.
    McAlhany SJ; Ressler SJ; Larsen M; Tuxhorn JA; Yang F; Dang TD; Rowley DR
    Cancer Res; 2003 Sep; 63(18):5859-65. PubMed ID: 14522910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stromal cells promote angiogenesis and growth of human prostate tumors in a differential reactive stroma (DRS) xenograft model.
    Tuxhorn JA; McAlhany SJ; Dang TD; Ayala GE; Rowley DR
    Cancer Res; 2002 Jun; 62(11):3298-307. PubMed ID: 12036948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-like growth factor binding protein-3 (IGFBP-3) in the prostate and in prostate cancer: local production, distribution and secretion pattern indicate a role in stromal-epithelial interaction.
    Massoner P; Haag P; Seifarth C; Jurgeit A; Rogatsch H; Doppler W; Bartsch G; Klocker H
    Prostate; 2008 Aug; 68(11):1165-78. PubMed ID: 18459102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum macrophage inhibitory cytokine-1 concentrations correlate with the presence of prostate cancer bone metastases.
    Selander KS; Brown DA; Sequeiros GB; Hunter M; Desmond R; Parpala T; Risteli J; Breit SN; Jukkola-Vuorinen A
    Cancer Epidemiol Biomarkers Prev; 2007 Mar; 16(3):532-7. PubMed ID: 17372249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibroblast growth factor-2 mediates transforming growth factor-beta action in prostate cancer reactive stroma.
    Yang F; Strand DW; Rowley DR
    Oncogene; 2008 Jan; 27(4):450-9. PubMed ID: 17637743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage inhibitory cytokine 1 reduces cell adhesion and induces apoptosis in prostate cancer cells.
    Liu T; Bauskin AR; Zaunders J; Brown DA; Pankhurst S; Russell PJ; Breit SN
    Cancer Res; 2003 Aug; 63(16):5034-40. PubMed ID: 12941831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-induced anorexia and weight loss are mediated by the TGF-beta superfamily cytokine MIC-1.
    Johnen H; Lin S; Kuffner T; Brown DA; Tsai VW; Bauskin AR; Wu L; Pankhurst G; Jiang L; Junankar S; Hunter M; Fairlie WD; Lee NJ; Enriquez RF; Baldock PA; Corey E; Apple FS; Murakami MM; Lin EJ; Wang C; During MJ; Sainsbury A; Herzog H; Breit SN
    Nat Med; 2007 Nov; 13(11):1333-40. PubMed ID: 17982462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of macrophage inhibitory cytokine-1 in prostate cancer bone metastases induces osteoclast activation and weight loss.
    Wakchoure S; Swain TM; Hentunen TA; Bauskin AR; Brown DA; Breit SN; Vuopala KS; Harris KW; Selander KS
    Prostate; 2009 May; 69(6):652-61. PubMed ID: 19152406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The TGF-beta superfamily cytokine MIC-1/GDF15: secretory mechanisms facilitate creation of latent stromal stores.
    Bauskin AR; Jiang L; Luo XW; Wu L; Brown DA; Breit SN
    J Interferon Cytokine Res; 2010 Jun; 30(6):389-97. PubMed ID: 20187768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression profiling of PC-3 cell line variants and comparison of MIC-1 transcript levels in benign and malignant prostate.
    Patrikainen L; Porvari K; Kurkela R; Hirvikoski P; Soini Y; Vihko P
    Eur J Clin Invest; 2007 Feb; 37(2):126-33. PubMed ID: 17217378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smad3 is overexpressed in advanced human prostate cancer and necessary for progressive growth of prostate cancer cells in nude mice.
    Lu S; Lee J; Revelo M; Wang X; Lu S; Dong Z
    Clin Cancer Res; 2007 Oct; 13(19):5692-702. PubMed ID: 17908958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-like growth factor I secreted from prostate stromal cells mediates tumor-stromal cell interactions of prostate cancer.
    Kawada M; Inoue H; Masuda T; Ikeda D
    Cancer Res; 2006 Apr; 66(8):4419-25. PubMed ID: 16618768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant neuropeptide Y and macrophage inhibitory cytokine-1 expression are early events in prostate cancer development and are associated with poor prognosis.
    Rasiah KK; Kench JG; Gardiner-Garden M; Biankin AV; Golovsky D; Brenner PC; Kooner R; O'neill GF; Turner JJ; Delprado W; Lee CS; Brown DA; Breit SN; Grygiel JJ; Horvath LG; Stricker PD; Sutherland RL; Henshall SM
    Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):711-6. PubMed ID: 16614113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of transforming growth factor-beta signaling suppresses progression of androgen-independent human prostate cancer in nude mice.
    Zhang F; Lee J; Lu S; Pettaway CA; Dong Z
    Clin Cancer Res; 2005 Jun; 11(12):4512-20. PubMed ID: 15958637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of macrophage inhibitory cytokine-1/prostate derived factor in benign prostatic hyperplasia.
    Kakehi Y; Segawa T; Wu XX; Kulkarni P; Dhir R; Getzenberg RH
    Prostate; 2004 Jun; 59(4):351-6. PubMed ID: 15065082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of serum levels of macrophage inhibitory cytokine 1 combined with prostate-specific antigen improves prostate cancer diagnosis.
    Brown DA; Stephan C; Ward RL; Law M; Hunter M; Bauskin AR; Amin J; Jung K; Diamandis EP; Hampton GM; Russell PJ; Giles GG; Breit SN
    Clin Cancer Res; 2006 Jan; 12(1):89-96. PubMed ID: 16397029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting ECM-integrin interaction with liposome-encapsulated small interfering RNAs inhibits the growth of human prostate cancer in a bone xenograft imaging model.
    Bisanz K; Yu J; Edlund M; Spohn B; Hung MC; Chung LW; Hsieh CL
    Mol Ther; 2005 Oct; 12(4):634-43. PubMed ID: 16039164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factor-beta1 modulates tumor-stromal cell interactions of prostate cancer through insulin-like growth factor-I.
    Kawada M; Inoue H; Arakawa M; Ikeda D
    Anticancer Res; 2008; 28(2A):721-30. PubMed ID: 18507013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumour-stroma interactions between metastatic prostate cancer cells and fibroblasts.
    Kaminski A; Hahne JC; Haddouti el-M; Florin A; Wellmann A; Wernert N
    Int J Mol Med; 2006 Nov; 18(5):941-50. PubMed ID: 17016625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.